4.89

2.40% -0.12

Outset Medical Inc (OM)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt OM? Forum Prognose

Schlusskurs vom Vortag:

$5.01

Offen:

$5.05

24-Stunden-Volumen:

180.45K

Relative Volume:

1.03

Marktkapitalisierung:

$90.65M

Einnahmen:

$117.59M

Nettoeinkommen (Verlust:

$-74.85M

KGV:

-1.1713

EPS:

-4.175

Netto-Cashflow:

$-34.25M

1W Leistung:

+13.19%

1M Leistung:

+16.99%

6M Leistung:

+7.24%

1J Leistung:

-72.23%

1-Tages-Spanne:

$4.78

$5.2899

1-Wochen-Bereich:

$4.205

$5.38

52-Wochen-Spanne:

$3.00

$21.98

Outset Medical Inc Stock (OM) Company Profile

Firmenname

Outset Medical Inc

Sektor

Healthcare (1108)

Branche

Medical Devices (143)

Telefon

669-231-8200

Adresse

3052 ORCHARD DRIVE, SAN JOSE

Mitarbeiter

310

Twitter

Nächster Verdiensttermin

2026-05-07

Neueste SEC-Einreichungen

OM's Discussions on Twitter

Compare OM vs ABT, SYK, MDT, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OM Outset Medical Inc	4.89	92.87M	117.59M	-74.85M	-34.25M	-4.175
ABT Abbott Laboratories	85.60	150.32B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	305.09	117.93B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	73.81	97.02B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	48.31	72.99B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.47	49.50B	6.30B	1.07B	1.09B	1.8406

Outset Medical Inc Stock (OM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-08	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2024-06-21	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2024-04-08	Eingeleitet	BTIG Research	Buy
2024-04-05	Hochstufung	CL King	Neutral → Buy
2024-01-12	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2023-10-13	Herabstufung	BofA Securities	Buy → Underperform
2023-08-17	Eingeleitet	CL King	Neutral
2022-11-11	Eingeleitet	RBC Capital Mkts	Outperform
2022-07-14	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-03-02	Fortgesetzt	BofA Securities	Buy
2022-02-17	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2021-08-18	Eingeleitet	Cowen	Outperform
2021-04-19	Eingeleitet	Wells Fargo	Overweight
2020-12-16	Eingeleitet	Oppenheimer	Perform
2020-10-12	Eingeleitet	Barclays	Overweight
2020-10-12	Eingeleitet	BofA Securities	Buy
2020-10-12	Eingeleitet	Goldman	Buy
2020-10-12	Eingeleitet	Morgan Stanley	Equal-Weight
2020-10-12	Eingeleitet	SVB Leerink	Mkt Perform
2020-10-12	Eingeleitet	Stifel	Buy

Alle ansehen

Outset Medical Inc Aktie (OM) Neueste Nachrichten

May 29, 2026

Outset Medical's Marc Nash to Depart as Executive Vice President, R&D, Operations and Service - TradingView

May 29, 2026

[8-K] Outset Medical, Inc. Reports Material Event - Stock Titan

May 29, 2026

May 26, 2026

Why Did Outset Medical Stock Tumble Today? - MSN

May 26, 2026

May 21, 2026

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

May 21, 2026

May 20, 2026

Outset Medical (OM) Price Target Decreased by 38.83% to 16.06 - MSN

May 20, 2026

Outset Medical: General counsel Brottem sells $9,760 in shares - Investing.com India

May 20, 2026

Outset Medical CEO Leslie Trigg sells $12,746 in OM shares - Investing.com India

May 20, 2026

Outset Medical: General counsel Brottem sells $9,760 in shares By Investing.com - Investing.com India

May 20, 2026

May 19, 2026

Outset Medical EVP Marc Nash sells $5,853 in common stock - Investing.com India

May 19, 2026

Outset Medical EVP Marc Nash sells $5,853 in common stock By Investing.com - Investing.com South Africa

May 19, 2026

Outset Medical CEO Leslie Trigg sells $12,746 in OM shares By Investing.com - Investing.com Nigeria

May 19, 2026

Outset Medical (OM) EVP sells 1,582 shares in tax-related ‘sell to cover’ - Stock Titan

May 19, 2026

May 18, 2026

BML Investment Partners takes 13.6% stake in Outset Medical (OM) - Stock Titan

May 18, 2026

Outset Medical (OM) major holder assigned 323K shares via June 2026 puts - Stock Titan

May 18, 2026

May 16, 2026

Outset Medical (OM) price target decreased by 14.81% to 7.82 - MSN

May 16, 2026

May 15, 2026

OM (NASDAQ: OM) settles 4,277 RSUs; Marc Nash sold 1,830 shares earlier - Stock Titan

May 15, 2026

OM (NASDAQ: OM) files Form 144 for 9,319 RSU settlement on 05/15/2026 - Stock Titan

May 15, 2026

OM (NASDAQ) director files Form 144 reporting 5,033 RSUs settled and prior sale - Stock Titan

May 15, 2026

Outset Medical (OM) amendment shows no beneficial ownership by Alyeska entities - Stock Titan

May 15, 2026

Here’s Why Outset Medical (OM) Rebound Sharply After Last Quarter’s Selloff - Insider Monkey

May 13, 2026

May 12, 2026

BML Investment Partners files 13G/A reporting 11.8% stake in Outset Medical (OM) - Stock Titan

May 12, 2026

Outset Medical (OM) 10% holder entities exercise derivatives to acquire over 294K shares - Stock Titan

May 12, 2026

Outset Medical to Present at RBC Global Healthcare Conference - The Manila Times

May 12, 2026

May 11, 2026

Dialysis tech firm Outset Medical to speak at RBC health conference - Stock Titan

May 11, 2026

Outset Medical net revenue drops 6% to USD 27.9M in Q1 2026 - Medical Buyer

May 11, 2026